정신 분열병(증)을 SEP-363856, a non–D2-receptor-binding antipsychotic drug으로 치료 한 결과 schizophrenia치료에 좋은 효과가 있다고 한다. Treatment of schizophrenia with SEP-363856, a non–D2-receptor-binding antipsychotic drug, is said to be effective in treating schizophrenia.
정신 분열병(증)을 SEP-363856, a non–D2-receptor-binding antipsychotic drug으로 치료 한 결과 schizophrenia치료에 좋은 효과가 있다고 한다. Treatment of schizophrenia with SEP-363856, a non–D2-receptor-binding antipsychotic drug, is said to be effective in treating schizophrenia. SEP-363856, a non–D2-receptor-binding antipsychotic drug, resulted in … Continued